EDISON, N.J.--(BUSINESS WIRE)--I-many, Inc. (NASDAQ:IMNY), the leading provider of advanced Contract Lifecycle Management (CLM) solutions for managing corporate commitments, today announced that Talecris Biotherapeutics has completed implementation of three I-many products that will empower them to optimize revenues associated with rebates, chargebacks, and accurate pricing, while also ensuring compliance with a range of regulations including Medicaid and the Deficit Reduction Act (DRA). Talecris has implemented I-many CARS®, I-many Medicaid™, and I-many Government Pricing™.
